MGS-0039

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMGS-0039
Drug Alias NameBCI-632MGS-0039
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionMetabotropic glutamate receptor 3 antagonistsMetabotropic glutamate receptor 2 antagonists
TargetsMetabotropic glutamate receptor 2Metabotropic glutamate receptor 3
Therapy Area/IndicationsCognition DisordersAnxietyDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBraincells IncTaisho Pharmaceutical Holdings Co Ltd
Active IndicationsN/A
Inactive IndicationsCognition DisordersAnxietyDepression

Other Information

ATC CodeN/A
Related LinksWikipedia